Victoza (liraglutide) In 2017, the FDA approved Victoza (liraglutide) to reduce the risk of heart disease and stroke
As a physician specializing in aesthetics and wellness, I am excited about Retatrutide, a new triple hormone receptor agonist that may be a game-changer for fat loss while preserving muscle mass
Hydration and Fluid Balance During GLP-1 Therapy Semaglutide users must drink 6080 ounces of water daily because dehydration amplifies nausea, dizziness, and constipationside effects already associated with the medication
This can result in more muscle mass, improved fat metabolism, enhanced skin quality, and potentially anti-aging effects
Personalized Protocol Your Medical Director designs a GHK Cu protocol based on your goals
Compounded formulations for microdosing Compounded tirzepatide from a licensed compounding pharmacy provides the flexibility needed for true microdosing